In addition, some studies have found that peripheral MCP-1 levels increased in T2DM patients, and MCP-1 expression levels were associated with insulin resistance (Degirmenci et al., 2019; Muzurović et al., 2021). The gene discussed is CCL2; the disease is Insulin resistance.